{ "cik": 882796, "cik_padded": "0000882796", "entityName": "BIOCRYST PHARMACEUTICALS INC", "fiscal_years": [ { "accn": "0001628280-26-012240", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2468000.0, "cash": 89736000.0, "eps_diluted": 1.21, "free_cash_flow": 344901000.0, "net_income": 263861000.0, "operating_cash_flow": 347369000.0, "operating_income": 340989000.0, "revenue": 874837000.0, "stockholders_equity": -119153000.0, "total_assets": 514158000.0, "total_liabilities": 633311000.0 }, "period_end": "2025-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": 0.3016116145064738, "operating_margin": 0.3897743236740101, "revenue_growth_yoy": 0.9410111113083299, "roa_avg2y": 0.5253170983238733, "roa_period_end": 0.5131904978625248, "roe_avg2y": -0.8867980648207741 } }, { "accn": "0001628280-26-012240", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1124000.0, "cash": 104713000.0, "eps_diluted": -0.43, "free_cash_flow": -53144000.0, "net_income": -88881000.0, "operating_cash_flow": -52020000.0, "operating_income": -2543000.0, "revenue": 450712000.0, "stockholders_equity": -475934000.0, "total_assets": 490420000.0, "total_liabilities": 966354000.0 }, "period_end": "2024-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.19720131702728128, "operating_margin": -0.00564218392232734, "revenue_growth_yoy": 0.35997489529648896, "roa_avg2y": -0.17645972721316683, "roa_period_end": -0.18123445210227968, "roe_avg2y": 0.19084192377144746 } }, { "accn": "0001628280-26-012240", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2168000.0, "cash": 110643000.0, "eps_diluted": -1.18, "free_cash_flow": -97309000.0, "net_income": -226539000.0, "operating_cash_flow": -95141000.0, "operating_income": -103709000.0, "revenue": 331412000.0, "stockholders_equity": -455528000.0, "total_assets": 516960000.0, "total_liabilities": 972488000.0 }, "period_end": "2023-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.6835570226787201, "operating_margin": -0.3129307327435337, "revenue_growth_yoy": 0.22370369276327692, "roa_avg2y": -0.424643847941816, "roa_period_end": -0.4382137883008356, "roe_avg2y": 0.6040033327778703 } }, { "accn": "0001628280-26-012240", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 1351000.0, "cash": 304767000.0, "eps_diluted": -1.33, "free_cash_flow": -163201000.0, "net_income": -247116000.0, "operating_cash_flow": -161850000.0, "operating_income": -148435000.0, "revenue": 270827000.0, "stockholders_equity": -294597000.0, "total_assets": 550000000.0 }, "period_end": "2022-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.9124496449763133, "operating_margin": -0.5480805089595941, "revenue_growth_yoy": 0.723146910988102, "roa_avg2y": -0.4342411507787631, "roa_period_end": -0.44930181818181825, "roe_avg2y": 1.2307094672832266 } }, { "accn": "0001628280-25-007715", "filed": "2025-02-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 2385000.0, "cash": 504389000.0, "eps_diluted": -1.03, "free_cash_flow": -144542000.0, "net_income": -184062000.0, "operating_cash_flow": -142157000.0, "operating_income": -177720000.0, "revenue": 157170000.0, "stockholders_equity": -106986000.0, "total_assets": 588151000.0 }, "period_end": "2021-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.1711013552204619, "operating_margin": -1.130750143157091, "revenue_growth_yoy": 7.82382663373007, "roa_avg2y": -0.3988921468555565, "roa_period_end": -0.31295024577021885, "roe_avg2y": 2.915879855522464 } }, { "accn": "0001628280-24-007205", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 514000.0, "cash": 272127000.0, "eps_diluted": -1.09, "free_cash_flow": -135622000.0, "net_income": -182814000.0, "operating_cash_flow": -135108000.0, "operating_income": -174757000.0, "revenue": 17812000.0, "stockholders_equity": -19262000.0, "total_assets": 334715000.0 }, "period_end": "2020-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.6352615951674004, "roa_avg2y": -0.7169218642462603, "roa_period_end": -0.5461780918094499, "roe_avg2y": -19.253712480252766 } }, { "accn": "0001628280-23-005259", "filed": "2023-02-27", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 343000.0, "cash": 114172000.0, "free_cash_flow": -89927000.0, "net_income": -108897000.0, "operating_cash_flow": -89584000.0, "operating_income": -99455000.0, "revenue": 48835000.0, "stockholders_equity": 38252000.0, "total_assets": 175282000.0 }, "period_end": "2019-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 1.3645475233622235, "roa_avg2y": -0.676120612312688, "roa_period_end": -0.6212674433199074, "roe_avg2y": -2.4894441459874037 } }, { "accn": "0001171843-22-001460", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 366000.0, "cash": 26731000.0, "free_cash_flow": -92931000.0, "net_income": -101252000.0, "operating_cash_flow": -92565000.0, "operating_income": -94220000.0, "revenue": 20653000.0, "stockholders_equity": 49235000.0, "total_assets": 146841000.0 }, "period_end": "2018-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.17998094179305962, "roa_avg2y": -0.6228975699784681, "roa_period_end": -0.6895349391518718, "roe_avg2y": -1.5225635704726244 } }, { "accn": "0001171843-21-001411", "filed": "2021-03-01", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 328000.0, "cash": 50282000.0, "free_cash_flow": -41471000.0, "net_income": -65782000.0, "operating_cash_flow": -41143000.0, "operating_income": -57411000.0, "revenue": 25186000.0, "stockholders_equity": 83767000.0, "total_assets": 178259000.0 }, "period_end": "2017-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.04428338329601943, "roa_avg2y": -0.49071635845523787, "roa_period_end": -0.3690248458703348, "roe_avg2y": -1.541554865545726 } }, { "accn": "0001171843-20-001710", "filed": "2020-03-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 5277000.0, "cash": 22104000.0, "free_cash_flow": -58715000.0, "net_income": -55144000.0, "operating_cash_flow": -53438000.0, "operating_income": -48607000.0, "revenue": 26353000.0, "stockholders_equity": 1578000.0, "total_assets": 89847000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.613754493750487 } } ], "latest_filing": { "accn": "0001628280-26-012240", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000882796.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000882796.json" }, "ticker": "BCRX" }